Marimastat therapy as adjuvant to selective embolization in skeletal metastases of differentiated thyroid carcinoma.
Smit
J W
JW
Department of Endocrinology, Leiden University Medical Center, The Netherlands. j.w.a.smit.endo@lumc.nl
van Tol
K M
KM
Hew
J M
JM
Vielvoye
G J
GJ
Romijn
J A
JA
Links
T P
TP
D000328:Adult; D000368:Aged; D001859:Bone Neoplasms / Q000556:secondary* / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D004621:Embolization, Therapeutic; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D008297:Male; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors; D008875:Middle Aged; D013964:Thyroid Neoplasms
D004791:Enzyme Inhibitors; D006877:Hydroxamic Acids; C100342:marimastat; D008666:Metalloendopeptidases